Point72 Hong Kong LTD Omeros Corp Transaction History

Point72 Hong Kong LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.92 - $6.28 $631 - $2,066	329 New	329 $1,000
Q3 2021 Nov 15, 2021	SELL	$13.4 - $16.3 $31,985 - $38,908	-2,387 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$14.81 - $19.13 $35,351 - $45,663	2,387 New	2,387 $35,000
Q4 2018 Feb 14, 2019	SELL	$10.72 - $16.73 $10,741 - $16,763	-1,002 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$17.73 - $26.69 $17,765 - $26,743	1,002 New	1,002 $24,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $712M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.